Dr. Fahdah Alokaily is a consultant rheumatologist at Prince Sultan Military Medical City (PSMMC) who regards patient care as her top priority. She has been the Editor in Chief of the Saudi Medical Journal for the past six years during which the impact factor of the journal has doubled. She also cooperates with the Royal College of Physicians in the UK as an international advisor.
Formerly, she held the position of Executive Director of Academic Affairs at PSMMC.

Dr. Fahdah Alokaily contributed significantly to medical training at varying levels. She chaired numerous conferences and organized training courses. She authored, co-authored and reviewed for many journals as well as conducted courses in medical journalism.

In 2020, she was awarded the Order of King Fahad of the third degree for her excellence in the medical field.

After graduating from King Saud University in Riyadh, she pursued her residency training in internal medicine at PSMMC and obtained her ABIM and MRCP. Then, she completed her fellowship training in rheumatology in PSMMC and the Royal London Hospital.

Prof. Hundt completed her thesis for veterinary medicine at the Veterinary School of Hanover in 2008. Until 2013 her research focused on hair follicle biology. Since then she continues her research in experimental dermatology, focusing on in vivo imaging of inflammatory processes. Prof. Hundt obtained a Degree in Veterinary Medicine at the Veterinary School of Hanover- Germany in 1999, then obtained a PhD from the Veterinary School of Hanover, Germany in 2008. Since 2008 Prof. Hundt hold a position of Professor for visualization of cutaneous inflammation, at Lübeck Institute of Experimental Dermatology, University of Lübeck, Germany. Prof Hundt has many publications in a reputable peer reviewed journal.

Marco Matucci-Cerinic is Full Professor of Rheumatology at the Department of Experimental and Clinical Medicine of the University of Florence and works in the Rheumatology Division of the Careggi University Hospital of Florence. The professor is a member of the prestigious British Royal College of Physicians, the American College of Rheumatology, the Italian Society of Rheumatology and is also an honorary member of the British Society of Rheumatology.
Prof. Matucci-Cerinic has served as executive secretary of ILAR, vice president of SCTC, secretary general of EULAR and founder of the EUSTAR group. He is currently president of the World Scleroderma Foundation and editor of the Journal of Scleroderma & Related Diseases. He is also Associate Editor of the Arthritis Research & Therapy and Clinical Experimental Rheumatology journals and member of the board of the Annals of the Rheumatic Diseases, Rheumatology, Journal of Rheumatology, Scandinavian Journal of Rheumatology, Pulmonary Circulation and other rheumatology journals.

He has published more than 1000 scientific papers in the field of rheumatology, in particular on the pathogenesis, clinical features and treatment of Raynaud’s phenomenon, pulmonary, cardiac and vascular involvement (digital ulcers) of systemic sclerosis, rheumatoid arthritis, psoriatic arthritis, spondyloarthritis and osteoarthritis.

Maria Esperanzo Naredo is a rheumatologist, joint amd bone research unit hospital Universatario Fundacion Jimenez Diaz Autonoma University Spain. Rheumatology residency in Hospital La Puz, Autonoma University, Madrid Spain. Full doctoral programme in the department of Internal Medicine. Founder of Ultrasound school of the spanish Society of Rheumatology. Past chair of EULAR Standing committee on Musculoskeletal Imaging, Published articles, book chapters and conferences concerning musculoskeletal ultrasound in rheumatology.

Dr.Hani obtained his medical degree from the Faculty of medicine at King Abdulaziz University in Jeddah, Saudi Arabia in 1996. After that, Dr.Hani pursued to complete a fellowship degree in internal medicine at the Royal College of Physicians & Surgeons of Canada in 2002, followed by another fellowship degree in rheumatology at the Royal College of Physicians & Surgeons of Canada, which he swimmingly completed in 2003, before successfully completing a fellowship degree in rheumatology at the university of British Columbia in Vancouver, Canada in 2004. In 2005, he acquired a diploma in medical education from the school of medicine at the university of Dundee in Scotland, UK.
Dr.Hani is board certified by the American Board of internal medicine in 2001 and the American Board of rheumatology in 2003, USA. Dr. Hani received Best Teaching Clinical Fellow Award, University of British Columbia, 2003. DR. Hani author of 45 Publications in Reviewed Journals, author of “Systemic Lupus” Book, and author of “Skills in Rheumatology” Book

Dr. Ibrahim Yaseen Hachim is Assistant Professor in Pathology, College of Medicine, Department of Clinical Sciences, Sharjah university. Dr. Ibrahim is a medical doctor with M.Sc. in histopathology. He obtained his Ph.D. from Cancer Research Program, College of Medicine, McGill University, Montreal, Canada.
Dr. Hachim is known for his research work in the field of molecular pathology. His research interest includes. molecular pathology.

Dr. Ibrahim had more than 40 publications in different prestigious journals. During his career, Dr. Ibrahim received several awards including two doctoral scholarships, two Graduate Excellence Award, George G. Harris Fellowship in Cancer, McGill University, Montreal, Canada. In addition, to Pauline Blinder Krupp Award for the most promising clinical researchers in Montreal, Canada.

Khalid Alnaqbi is a Consultant and Head of Rheumatology and Immunology at Tawam hospital, UAE. Ex- Head of Rheumatology and Immunology at Al Ain hospital, UAE graduated from the College of Medicine and Health Sciences at UAE University. He completed his post-graduate residency training at the University of Toronto in Internal Medicine and Rheumatology and then undertook a fellowship at the Spondyloarthritis Program. He holds multiple board certifications in Internal Medicine and Rheumatology (American Board of Internal Medicine, and Royal College of Physicians and Surgeons of Canada, RCPSC).
Dr. Alnaqbi pursued his academic interests by completing the Clinician Investigator Program with a thesis-based Master of Science (MSc). The thesis was on development of a new instrument to detect spondyloarthritis in patients with inflammatory bowel disease. He has published in peer-reviewed journals. He is a journal reviewer in prestigious journals. He wrote a book chapter on (Diagnosis of Ankylosing Spondylitis) in a book (Advances in the Management of Ankylosing Spondylitis).

Dr. Alnaqbi is a Fellow of the American College of Physicians (FACP), a Fellow of the American College of Rheumatology (FACR), and a Fellow of the RCPSC (FRCPC). He is a member in the Assessment of Spondyloarthritis international Society (ASAS), and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). He has been a speaker in numerous national and international meetings.

Dr.L.Jeyaseelan is a Professor of Biostatistics at the MBRU of Medicine and Health Sciences, Dubai, UAE, and a Fellow of International Clinical Epidemiology (INCLEN) network. Dr.L.Jeyaseelan pursued one year Fellowship on Advanced level Biostatistics, Clinical Epidemiology and Epidemiology at the University of New Castle, Australia in 1989-90. I am awarded PhD in Biostatistics in 1989. Since then, Dr.L.Jeyaseelan trained Medical graduates (Bachelor (MBBS) and Masters (MD & MS)), Master’s students in Public Health, MSc Nursing and PhD students in statistical methods, epidemiology and computing.
Dr.L.Jeyaseelan worked as Visiting Professor at the University of Washington from 2004-2006. Dr.L.Jeyaseelan worked in Sultan Qaboos University Hospital as Consultant Professor for two years. During this period Dr.L.Jeyaseelan have conducted 22 workshops for the faculty members of the university. Dr.L.Jeyaseelan have been actively involved in conduction basic and advanced level Biostatistics and Epidemiological workshops since 2001. Dr.L.Jeyaseelan have had collaborations with University of North Carolina, McMaster University and University of Oklohama. Based on these collaborations I was able to conduct some advanced level topics such as Diagnostics Test, Latent class models etc. (refer site: https://cmc-biostatistics.ac.in/pasteventlist.php ).

Dr.L.Jeyaseelan served as PI, Co-PI on National level projects in India. Dr.L.Jeyaseelan served as a member of Data Safety Monitoring Board (DSMB) of WHO Polio Studies . He has more than 200 papers published in national and international journals. Dr.L.Jeyaseelan developed a sample size calculation software “nMaster”, which is being marketed, promoted and appreciated widely now in India (Site: https://nmaster.cmc-biostatistics.ac.in/).

Dr Merashli is a rheumatology Consultant and medical director of rheumatology training program at the American University Hospital of Beirut since 2016. She obtained her rheumatology training at the Royal London Hospital in UK in 2015. She is a current fellow at the Royal college of physicians in London. Has published more than 50 papers in peer reviewed journals.

Dr. Radhakrishnan is a pharmacologist and a US-registered pharmacist in the States of Utah and West Virginia, currently serving as a professor of pharmacology at the Mohammed Bin Rashid University College of Medicine in Dubai. He has more than 20 years of combined experience in teaching, research, and academic administration. He received his BPharm degree from the University of Kerala, India; MSc in pharmacology from the University of Strathclyde, UK; and PhD in pharmacology from the National University of Singapore (NUS). He did his postdoctoral fellowship in pain neurobiology at the University of Iowa, USA. Dr. Radhakrishnan has taught pharmacology to pharmacy, medical and dental students in different universities in Malaysia, USA and UAE. He has also served as the Academic Affairs Dean at the Schools of Pharmacy in Roseman University and University of Charleston in the USA. Dr. Radhakrishnan has been an active member of the American Association of Colleges of Pharmacy (AACP), American Pain Society (APS), and Society for Neuroscience (SFN). He has published 40 peer-reviewed research articles, 5 book chapters and several abstracts. He is one of the editors of Phytotherapy Research (Wiley), and Editorial Board Member of Journal of Pain (Elsevier) and Inflammopharmacology (Springer). He is also a collaborating editor of Lippincott Illustrated Reviews: Pharmacology 7e. Dr. Radhakrishnan serves as a reviewer for more than 15 international scientific journals. His current research interests are pain neurobiology, mechanisms of inflammatory pain, pharmacology & toxicology of natural products, and scholarship of teaching and learning (SoTL).

Saba Al Heialy is an Assistant Professor of Immunology at Mohammed bin Rashid University of Medicine, Dubai, UAE and Health Sciences and Adjunct Professor at McGill University, Montreal, Canada. She obtained her PhD degree in 2013 at McGill University where she trained at the Meakins-Christie laboratory, a leading research center in respiratory medicine. She has received numerous awards and most notably the L’Oreal-UNESCO For Women in Science fellowship in 2017 followed by the prestigious L’Oreal-UNESCO International Rising Talents in 2019 for her research in obesity and asthma. She is currently funded for various projects revolving around the immune responses in different respiratory disease such as asthma and COVID-19 in collaboration with international and national institutions. She has published several papers on the immune response in COVID-19 and in particular is interested in the role of obesity in the current pandemic.

A professional with proven accomplishments in medical research and innovation, clinical trials, clinical audits, research ethics & regulations, Joint Commission accreditation, health technology incubators, care quality, medical residency training, and patient safety. I have the unique distinction of serving in the senior management of multinational pharmaceutical industries, and as a faculty for academic medical centers, hospitals, and research centers in the USA, and the UAE.
The original inventor of the human major depressive disorder gene. Recipient of several global awards from the USA, Japan, Switzerland, including the Innovator of the Year in Medicine 2018-2019, and Technology Innovation Pioneer (2020) from the government of the UAE. Published in Lancet (2020), Breast (2020) & Contemporary Clinical Trials (2020) and International Journal Public Health (2021)